The AUR87A study found that urine collected biomarkers could accurately predict recurrence of kidney cancer in post-surgery ...

Agilent Technologies Inc. (NYSE: A) today announced its PD-L1 IHC 28-8 pharmDx kit has received two new companion diagnostic indications approvals under EU IVDR 1, expanding the eligibility of ...

March 10, 2025--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced its PD-L1 IHC 28-8 pharmDx kit has ... to early-stage non-small cell lung cancer (NSCLC) and previously ...

Agilent PD-L1 IHC 28-8 pharmDx Receives EU IVDR Certification as a Companion Diagnostic Test for Non-small Cell Lung Cancer and Melanoma Indications Agilent Technologies Inc. (NYSE: A) today ...

Source: Getty Images At an early stage, basal cell carcinoma is small and confined, and usually can be cured. When the cancer gets larger and grows deeper in the skin or spreads to other organs ...

This open access article is distributed under the Creative Commons Attribution 4.0 International (CC BY 4.0) license. This work is licensed under a Creative Commons Attribution 4.0 International ...

Serum amylase and lipase levels were raised (228 U/L and 616 U/L respectively), liver and renal function tests ... small round blue cell in the papillary as well as reticular dermis. Epidermotropism ...

The Business Research Company The Business Research Company's Renal Cell Carcinoma Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 Updated 2025 Market Reports Releas... ...